24252-38-8

Usage

Uses

Used in Pharmaceutical Research and Development:
1-Ethylpiperidine-4-carboxylic acid ethyl ester is used as a building block for the synthesis of various bioactive compounds, contributing to the development of new pharmaceuticals with potential therapeutic applications.
Used in Chemical Production:
1-ETHYLPIPERIDINE-4-CARBOXYLIC ACID ETHYL ESTER is utilized as a precursor in the production of other chemicals, playing a crucial role in the synthesis of a range of chemical products.
Used in Pharmaceutical Ingredients:
1-Ethylpiperidine-4-carboxylic acid ethyl ester is employed in the formulation of pharmaceutical ingredients, enhancing the effectiveness and versatility of medications in the healthcare industry.

InChI:InChI=1/C10H19NO2/c1-3-11-7-5-9(6-8-11)10(12)13-4-2/h9H,3-8H2,1-2H3

Upstream product

• 1126-09-6 4-carbethoxypiperidine 
• 75-00-3 chloroethane 
• 75-03-6 ethyl iodide 
• 113977-53-0 4-ethoxycarbonyl-1-ethyl-pyridinium; bromide 

Downstream Products

• 90204-94-7 1-ethylpiperidine-4-carboxylic acid 

Relevant academic research and scientific papers

SUBSTITUTED BENZAZOLES AND USE THEREOF AS INHIBITORS OF RAF KINASE

New substituted benzazole compounds of formula (I), compositions and methods of inhibition of Raf kinase activity in a human or animal subject are provided. The new compounds compositions may be used either alone or in combination with at least one additi

Carbamoyloxy derivatives of mutiline and their use as antibacterials

PCT No. PCT/EP96/05874 Sec. 371 Date Dec. 4, 1998 Sec. 102(e) Date Dec. 4, 1998 PCT Filed Dec. 19, 1996 PCT Pub. No. WO97/25309 PCT Pub. Date Jul. 17, 1997Derivatives of mutiline of formula (1A) and pharmaceutically acceptable salts and derivatives thereof, in which R1 is ethyl or vinyl, Y is a carbamoyloxy group, in which the N-atom is unsubstituted, or mono- or di-substituted, are useful in the treatment of bacterial infections.

Synthesis and pharmacological evaluation of a new class of 2-oxo-8- azaspiro (4,5)decan-1-ones as analogues of the muscarinic agonist RS-86

A new series of 8-substituted-2-oxo-8-azapsiro (4,5)decan-1-ones has been synthesized and compounds tested for their cholinergic properties in comparison with the muscarinic agonist RS-86. Preliminary in vitro and in vivo pharmacological data indicate that none of them is provided with significant cholinergic effects either at central or peripheral level. A possible explanation for the lack of activity is given on the basis of conformational studies.